Gram-negative pathogens producing carbapenemases represent an alarming clinical threat
with serious effects on patient outcomes (3, 7). In 2001, Yigit et al.(11) reported a novel …

ABSTRACT From March 2009 to May 2009, 24 carbapenem-resistant Klebsiella
pneumoniae isolates were recovered from 16 patients hospitalized in an Italian intensive …

Background. We describe the emergence and spread of Klebsiella pneumoniae
carbapenemase 2 (KPC-2)–producing K. pneumoniae at a Greek University hospital …

KPC-type carbapenemases are emerging resistance determinants in Klebsiella
pneumoniae and other gram-negative pathogens, being an increasingly important …

Carbapenem-resistant gram-negative pathogens represent an emerging threat to the
management of hospital-acquired infections. Although the isolation of carbapenem-resistant …

Background. Klebsiella pneumoniae carbapenemase (KPC)–producing K. pneumoniae has
become endemic in many US hospitals. On the other hand, KPC-producing Escherichia coli …

Background The emergence of KPC-producing K. pneumoniae has now become a global
concern. KPC beta-lactamases are plasmid-borne and, like extended spectrum beta …

Objectives KPC-possessing Klebsiella pneumoniae have been found to be widespread in
several regions but are still rarely detected in Europe. We describe the characteristics of an …

AKPC-producing Klebsiella pneumoniae isolate was first de-scribed in the United States (1),
and strains with the carbapenemase enzyme have more recently been described as having …

Carbapenem-resistant K. pneumoniae has recently been reported as a new multidrug-
resistant nosocomial pathogen. This study reports the emergence of carbapenem-resistant …